Publications by authors named "Neil P Robertson"

Claim this Profile
E
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Jeremy Chataway, Thomas Williams, James Blackstone, Nevin John, Marie Braisher, Neil P Robertson

Lancet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis.
Laura Davies, Rasheed Shehadeh, W John Watkins, Stephen Jolles, Neil P Robertson

J Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bruton's tyrosine kinase inhibitor for multiple sclerosis: new hope or false dawn.
Neil P Robertson

J Neurol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.
Izanne Roos, Sifat Sharmin, Charles Malpas, Serkan Ozakbas, Jeannette Lechner-Scott, Neil P Robertson

Mult Scler· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world persistence of multiple sclerosis disease-modifying therapies.
Emma C Tallantyre, Ruth Dobson, Joseph L J Froud, Frederika A St John, Valerie M Anderson, Neil P Robertson

Eur J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the treatment of the muscular dystrophies.
Callum Wood, Neil P Robertson

J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort.
Emeka C Uzochukwu, Katharine E Harding, James Hrastelj, Karim L Kreft, Peter Holmans, Neil P Robertson

Neuroepidemiology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic criteria for MOGAD.
Sophie Voase, Neil P Robertson

J Neurol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prodromal multiple sclerosis: considerations and future utility.
Katharine E Harding, Karim L Kreft, Yoav Ben-Shlomo, Neil P Robertson

J Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials.
Yasmin Zid, Neil P Robertson

J Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real-World Cohort.
Karim L Kreft, Emeka Uzochukwu, Sam Loveless, Mark Willis, Ray Wynford-Thomas, Neil P Robertson

Ann Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel biomarkers and neuroimaging techniques in Parkinson's disease.
A Saw, S Bari, Neil P Robertson

J Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.
Eleftheria Kodosaki, W John Watkins, Sam Loveless, Karim L Kreft, Aidan Richards, Neil P Robertson

J Neuroinflammation· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cavernomas: to treat or not to treat?
Sophie Voase, Neil P Robertson

J Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Navigating the network": localising the lesion with the advent of lesion network mapping.
Jack Sheppard, Ray Wynford-Thomas, Neil P Robertson

J Neurol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?
Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, Anna Francis, Chanjira Satukijchai, Neil P Robertson

Ann Neurol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third Edition.
Andrew J Solomon, Ruth Ann Marrie, Shanthi Viswanathan, Jorge Correale, Melinda Magyari, Neil P Robertson

Neurology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Path from discovery to recovery: therapeutic and diagnostic advances in Alzheimer's dementia.
Aung M Saw, James Hrastelj, Neil P Robertson

J Neurol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination.
Safiya A Zaloum, Callum H Wood, Pooja Tank, Mae Upcott, Nicola Vickaryous, Neil P Robertson

Mult Scler· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary study of multiple sclerosis disability in South East Wales.
Katharine Elizabeth Harding, Gillian Ingram, Emma Clare Tallantyre, Fady Joseph, Mark Wardle, Neil P Robertson

J Neurol Neurosurg Psychiatry· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Tourette's syndrome.
Neil P Robertson

J Neurol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyotrophic lateral sclerosis: an update on treatments from clinical trials.
Ray Wynford-Thomas, Neil P Robertson

J Neurol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the genetics of stroke risk and recovery.
Sabbiha Nadia Majumder, James Hrastelj, Neil P Robertson

J Neurol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment.
Karim L Kreft, Neil P Robertson

J Neurol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis.
Emma C Tallantyre, Martin J Scurr, Nicola Vickaryous, Aidan Richards, Valerie Anderson, Neil P Robertson

Mult Scler Relat Disord· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis